Novavax, Inc. (NVAX)
9.11
-0.09
(-0.98%)
USD |
NASDAQ |
Feb 23, 12:41
Novavax Price : 9.11 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 123.57 |
| Pfizer Inc. | 27.07 |
| Moderna, Inc. | 50.40 |
| Recursion Pharmaceuticals, Inc. | 3.34 |
| Plus Therapeutics, Inc. | 0.279 |
Price Related Metrics
| PE Ratio | 5.151 |
| PS Ratio | 1.449 |
| Earnings Yield | 19.41% |
| Market Cap | 1.480B |
| Operating PE Ratio | 3.702 |
| Normalized PE Ratio | 3.857 |